326. 大理石骨病 Osteopetrosis Clinical trials / Disease details

臨床試験数 : 18 / 薬物数 : 43 - (DrugBank : 14) / 標的遺伝子数 : 17 - 標的パスウェイ数 : 82

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02065869 (ClinicalTrials.gov)	April 2014	13/2/2014	Safety Study of Gene Modified Donor T-cells Following TCRaß+ Depleted Stem Cell Transplant	Phase I/II Study of CaspaCIDe T Cells (BPX-501; Rivogenlecleucel) From an HLA Partially Matched Fami ...	Acute Lymphoblastic Leukemia;Leukemia, Acute Myeloid (AML), Child;Lymphoma, Non-Hodgkin;Myelodysplas ...	Biological: BPX-501 T cells;Drug: Rimiducid	Bellicum Pharmaceuticals	NULL	Active, not recruiting	1 Month	18 Years	All	187	Phase 1/Phase 2	Italy;United Kingdom;Germany;Spain;United States
2	EUCTR2014-000584-41-GB (EUCTR)		15/07/2015	Phase I/II study of CaspaCide T cells in children following aß- depleted mis-matched family donor st ...	Phase I/II study of CaspaCide T cells from an HLA-partially matched family donor after negative sele ...	Hematological disorders (ALL; AML; Non-Hodgkin lymphoma; Myelodysplastic syndromes; Congenital immun ...	Product Name: BPX-501 cells INN or Proposed INN: Rivogenlecleucel Other descriptive name: BPX-501 Produc ...	Bellicum Pharmaceuticals, Inc.	NULL	NA			Female: yes Male: yes	175	Phase 2	Spain;Italy;United Kingdom

First Previous1Next Last